# Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI

Study · id `cardio:ct-nct02012140` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02012140](<https://clinicaltrials.gov/study/NCT02012140>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02012140

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT02012140. Non-randomized; no masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2015-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT02012140, source copy `cardio:ctgov-nct02012140-2013-12-16`, retrieved 2026-10-26)
- Start date: 2014-01 (registry gives no type) (ClinicalTrials.gov record NCT02012140, source copy `cardio:ctgov-nct02012140-2013-12-16`, retrieved 2026-10-26)
- Primary completion: 2015-01 (anticipated) (ClinicalTrials.gov record NCT02012140, source copy `cardio:ctgov-nct02012140-2013-12-16`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: United States (ClinicalTrials.gov record NCT02012140, source copy `cardio:ctgov-nct02012140-2013-12-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02012140-2013-12-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI
- Condition: Cardiovascular Disease
- Condition: Stable Angina
- Condition: Myocardial Infarction
- Condition: Coronary Artery Disease
- Intervention (Drug): ticagrelor
- Lead sponsor: LifeBridge Health
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Stable angina (`cardio:stable-angina`)
- Registry intervention name matches this record: Ticagrelor (`cardio:ticagrelor`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)

## Provenance

Content hash: 71434b8bdfb8cf69a2face7b989b60ea7987ebac9057838eabf66319e40cb79d
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
